Covid-19 roundup: Gilead aims remde­sivir to­ward help­ing In­dia out­break; Mer­ck pairs with 5 In­di­an gener­ics man­u­fac­tur­ers for mol­nupi­ravir

As the num­ber of Covid-19 cas­es in In­dia dra­mat­i­cal­ly in­creas­es, Gilead will do­nate 450,000 vials of its remde­sivir drug to the gov­ern­ment.

The com­pa­ny an­nounced the move in a re­lease on Mon­day. Gilead is of­fer­ing tech­ni­cal as­sis­tance sup­port for new lo­cal man­u­fac­tur­ing fa­cil­i­ties and do­na­tions of APIs to scale up the pro­duc­tion of the drug — com­mer­cial­ly named Vek­lury — to help cut down on the re­cent surge.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER